Delivery Order SPE2DB20D1004-SPE2DB21FF8V8
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of a prescription medication, Lyrica 150 mg capsules. The contract has a ceiling value of $3,817.98 and a performance period ending on September 19, 2024. The contract is a firm-fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Lyrica 75 mg capsules. The contract has a ceiling value of $2,693.45 and is a firm fixed-price delivery order with an ultimate completion date of April 4, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lyrica 75 mg capsules. The contract has a ceiling value of $1,923.45 and a period of performance through May 1, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 90 count Lyrica 25 mg capsules. The contract has a ceiling value of $1,240.88 and is a firm fixed price, non-set-aside contract. The period of performance extends to July 2, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lyrica 50 mg capsules. The $1,182.32 contract has a completion date of July 14, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,875.27, is for the supply of Lyrica 25 mg capsules. The contract is a firm fixed-price delivery order with an ultimate completion date of April 4, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lyrica 100 mg capsules. The contract has a ceiling value of $2,692.65 and runs through March 5, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation indicated. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $3,778.94, is for the delivery of Lyrica 300 mg capsules. It is a firm fixed-price delivery order contract with a period of performance ending on March 14, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 50 mg capsules, a medication used for various medical conditions. The contract has a ceiling value of $7,203.50 and a completion date of May 16, 2024. It is a firm-fixed-price contract, which means the price will not change regardless of the contractor's actual costs. The...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Lyrica 150 mg capsules. The contract has a firm fixed price of $3,459.54 and a completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB21FF8V8Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lyrica 200 mg capsules. The contract has a ceiling value of $9,346.79 and a performance period ending on July 30, 2021. The contract was awarded on a firm-fixed-price basis without any set-aside requirements, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 7/29/21 |